Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fausto Roila

Showing results (51-60 of 99) with videos related to

Pageof 10
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 14, 2004
Radiotherapy-induced nausea and vomiting (RINV): antiemetic guidelinesPetra Ch Feyer, Ernesto Maranzano, Alexander Molassiotis, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 13, 2004
Antiemetics in children receiving chemotherapyFausto Roila, Petra Feyer, Ernesto Maranzano, et al.
Critical Reviews in Oncology/Hematology|January 15, 2013
Hepatitis B in immunosuppressed cancer patients: pathogenesis, incidence and prophylaxisMario Mandalà, Stefano Fagiuoli, Daniela Francisci, et al.
Seminars in Cancer Biology|June 25, 2022
Targeting inflamed and non-inflamed melanomas: biological background and clinical challengesAlice Indini, Daniela Massi, Matteo Pirro, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 19, 2004
Delayed emesis: moderately emetogenic chemotherapyFausto Roila, David Warr, Rebecca A Clark-Snow, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 23, 2016
2016 Updated MASCC/ESMO Consensus Recommendations: Prevention of Nausea and Vomiting Following High Emetic Risk ChemotherapyJørn Herrstedt, Fausto Roila, David Warr, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 15, 2016
Erratum to: 2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapyFausto Roila, David Warr, Paul J Hesketh, et al.
Tumori|March 10, 2010
Off-label prescription of antineoplastic drugs: an Italian prospective, observational, multicenter surveyFausto Roila, Enzo Ballatori, Roberto Labianca, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 12, 2016
2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapyFausto Roila, David Warr, Paul J Hesketh, et al.
Journal of Pain and Symptom Management|October 1, 2013
Evaluation of risk factors predicting chemotherapy-related nausea and vomiting: results from a European prospective observational studyAlexander Molassiotis, Matti Aapro, Mario Dicato, et al.
Pageof 10

Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 14, 2004
Radiotherapy-induced nausea and vomiting (RINV): antiemetic guidelinesPetra Ch Feyer, Ernesto Maranzano, Alexander Molassiotis, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 13, 2004
Antiemetics in children receiving chemotherapyFausto Roila, Petra Feyer, Ernesto Maranzano, et al.
Critical Reviews in Oncology/Hematology|January 15, 2013
Hepatitis B in immunosuppressed cancer patients: pathogenesis, incidence and prophylaxisMario Mandalà, Stefano Fagiuoli, Daniela Francisci, et al.
Seminars in Cancer Biology|June 25, 2022
Targeting inflamed and non-inflamed melanomas: biological background and clinical challengesAlice Indini, Daniela Massi, Matteo Pirro, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 19, 2004
Delayed emesis: moderately emetogenic chemotherapyFausto Roila, David Warr, Rebecca A Clark-Snow, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 23, 2016
2016 Updated MASCC/ESMO Consensus Recommendations: Prevention of Nausea and Vomiting Following High Emetic Risk ChemotherapyJørn Herrstedt, Fausto Roila, David Warr, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 15, 2016
Erratum to: 2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapyFausto Roila, David Warr, Paul J Hesketh, et al.
Tumori|March 10, 2010
Off-label prescription of antineoplastic drugs: an Italian prospective, observational, multicenter surveyFausto Roila, Enzo Ballatori, Roberto Labianca, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 12, 2016
2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapyFausto Roila, David Warr, Paul J Hesketh, et al.
Journal of Pain and Symptom Management|October 1, 2013
Evaluation of risk factors predicting chemotherapy-related nausea and vomiting: results from a European prospective observational studyAlexander Molassiotis, Matti Aapro, Mario Dicato, et al.
Pageof 10